NORTH CHICAGO, Ill. , Feb. 29, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Cowen and Company 36 th Annual Health Care Conference on Wednesday, March 9, 2016 . Richard A. Gonzalez , chairman and chief executive officer, will participate in a question and answer session at 8:20

NORTH CHICAGO, Ill. , Feb. 18, 2016 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.57 per share.  The cash dividend is payable May 16, 2016 to stockholders of record at the close of business on April 15, 2016 .

- Reports Full-Year Adjusted EPS of $4.29, Up 29.2 Percent; GAAP EPS of $3.13 - Delivers Full-Year Adjusted Net Revenues of $22.819 Billion, Up 22.1 Percent on an Operational Basis; GAAP Net Revenues of $22.859 Billion, Up 14.5 Percent - Expanded Adjusted Operating Margin to 42.3 Percent in 2015,

NORTH CHICAGO, Ill. , Jan. 7, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2015 financial results on Friday, Jan. 29, 2016 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).

NORTH CHICAGO, Ill. , Dec. 16, 2015 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 34 th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 13, 2016 . Richard A. Gonzalez , chairman and chief executive officer, will make a formal presentation on the company at 10:30 a.m.

NORTH CHICAGO, Ill. , Nov. 5, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Jefferies Autumn 2015 Global Healthcare Conference on Thursday, Nov. 19, 2015 . Bill Chase , executive vice president and chief financial officer, will participate in a question and answer session at 3:20

NORTH CHICAGO, Ill. , Nov. 2, 2015 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Credit Suisse 24 th Annual Healthcare Conference on Wednesday, Nov. 11, 2015 . Richard A. Gonzalez , chairman and chief executive officer, will participate in a question and answer session at 11 a.m.

- Reports Third-Quarter Adjusted EPS of $1.13, Up Nearly 27 Percent and Exceeding Previous Guidance Range of $1.04 to $1.06; Reports GAAP EPS of $0.74 - Delivers Third-Quarter Revenue of $5.944 Billion, an Increase of 26.2 Percent Over Third-Quarter 2014 on an Operational Basis (Excluding 7.8

- Company Expects to Deliver Double-Digit Adjusted Earnings-Per-Share (EPS) Growth on Average Through 2020 - Guides to Total Company Sales of Approximately $37 Billion in 2020 - Targeting 2020 Global HUMIRA Sales of More Than $18 Billion and IMBRUVICA Revenue of Approximately $5 Billion - Expects

NORTH CHICAGO, Ill. , Oct. 6, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2015 financial results on Friday, Oct. 30, 2015 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).